World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
95
Citations
40318
World Ranking
883
National Ranking
21

Overview

Davide Corti is affiliated with the Universita della Svizzera Italiana in Switzerland. Their research primarily centers on medicine, with a particular focus on infectious diseases, animal science and zoology, molecular biology, epidemiology, and genetics.

The scientist's work covers an array of topics including:

  • SARS-CoV-2 and COVID-19 research
  • Animal virus infections studies
  • COVID-19 clinical research studies
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing
  • Monoclonal and polyclonal antibodies research
  • Virus-based gene therapy research

Davide Corti has published extensively across various reputable venues, with a notable presence in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • UNC Libraries
  • Science
  • Cell

Some of the recent papers associated with Corti's research include:

  • "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody," 2020, Nature
  • "Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology," 2020, Cell
  • "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift," 2021, Nature
  • "Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies," 2021, Nature Medicine
  • "N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2," 2021, Cell

Frequent collaborators in their research include:

  • David Veesler
  • Antonio Lanzavecchia
  • Alexandra C. Walls
  • Gyorgy Snell
  • Herbert W. Virgin

Best Publications

  • Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.

    Dora Pinto;Young Jun Park;Martina Beltramello;Alexandra C. Walls

  • Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

    Unknown

  • Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.

    Luca Piccoli;Young Jun Park;M. Alejandra Tortorici;M. Alejandra Tortorici;Nadine Czudnochowski

  • A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

    Davide Corti;Jarrod Voss;Steven J. Gamblin;Giosiana Codoni

  • SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.

    Petra Mlcochova;Steven A Kemp;Steven A Kemp;Mahesh Shanker Dhar;Guido Papa

  • Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

    Unknown

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.

    Matthew McCallum;Anna De Marco;Florian A. Lempp;M. Alejandra Tortorici;M. Alejandra Tortorici

  • Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.

    Rita E. Chen;Xianwen Zhang;James Brett Case;Emma S. Winkler

  • Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

    Karin Stettler;Martina Beltramello;Diego A. Espinosa;Victoria Graham

  • Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

    Dami A. Collier;Dami A. Collier;Anna De Marco;Isabella A. T. M. Ferreira;Bo Meng

  • Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

    Alexandra C. Walls;Xiaoli Xiong;Young Jun Park;M. Alejandra Tortorici;M. Alejandra Tortorici

  • Broadly neutralizing antiviral antibodies

    Davide Corti;Antonio Lanzavecchia

  • Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.

    Emma C. Thomson;Emma C. Thomson;Laura E. Rosen;James G. Shepherd;Roberto Spreafico

  • Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

    M. Alejandra Tortorici;M. Alejandra Tortorici;Martina Beltramello;Florian A. Lempp;Dora Pinto

  • A perspective on potential antibody-dependent enhancement of SARS-CoV-2.

    Ann M. Arvin;Katja Fink;Michael A. Schmid;Andrea Cathcart

  • Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals

    Davide Corti;Johannes P. M. Langedijk;Andreas Hinz;Michael S. Seaman

  • Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

    Davide Corti;Amorsolo L. Suguitan;Debora Pinna;Chiara Silacci

  • SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.

    Tyler N. Starr;Nadine Czudnochowski;Zhuoming Liu;Fabrizia Zatta

  • SARS-like WIV1-CoV poised for human emergence

    Vineet D. Menachery;Boyd L. Yount;Amy C Sims;Kari Debbink

  • Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.

    James Brett Case;Paul W Rothlauf;Rita E Chen;Zhuoming Liu

  • Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

    Davide Corti;John Misasi;Sabue Mulangu;Daphne A. Stanley

  • Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.

    Bo Meng;Steven A Kemp;Steven A Kemp;Guido Papa;Rawlings Datir

Frequent Co-Authors

Antonio Lanzavecchia
Antonio Lanzavecchia Istituto Nazionale Genetica Molecolare
David Veesler
David Veesler University of Washington
Alexandra C. Walls
Alexandra C. Walls University of Washington
Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Nigel J. Temperton
Nigel J. Temperton University of Kent
Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Eric F. Donaldson
Eric F. Donaldson Center for Drug Evaluation and Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open doors to dynamic career paths. Nursing pathways, particularly advanced practice roles, are closely tied to immunology concepts and patient care.

Many students seek the easiest nurse practitioner degree programs that balance rigorous study with achievable completion times. These programs offer flexible online formats ideal for those juggling work and study.

Mental health is another critical area connected to immunological research. Aspiring psychiatric nurse practitioners can benefit from pmhnp programs online with best clinical placement, which ensure quality hands-on training opportunities essential for career readiness.

Cost-effective education is often a major consideration. The cheapest psychiatric nurse practitioner programs provide affordable paths without sacrificing quality, making them popular choices among students.

Graduates holding a doctorate in nursing salary can expect competitive compensation that varies by state, reflecting the increasing demand for advanced nursing professionals in healthcare focused on immunity and wellness.

Best Scientists Citing Davide Corti

Trending Scientists

Recently Published Articles